Ankit Rathod
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ankit Rathod has a total of 217 co-authors. Here are the top co-authors by number of shared publications:
Luis Afonso
16 shared publicationsApurva Badheka
14 shared publicationsSony Jacob
14 shared publicationsVikas Veeranna
Department of Medicine, Wayne State University/Detroit Medical Center, Detroit, MI, USA
12 shared publicationsPalaniappan Manickam
10 shared publications- Luis Afonso
Department of Medicine, Division of Cardiology, Wayne State University, Detroit, Michigan, USA
9 shared publications
Latest Publications
- Open Access
- 18 December 2017
- Published by Komitet Redakcyjno - Wydawniczy Polskiego Towarzystwa Psychiatrycznego in Archives of Psychiatry and Psychotherapy
- Vol. 19 (4) , 51-56
Anxiety and depression in spouses of males diagnosed with alcohol dependence: a comparative study
Aim of the study: In this study, we aim to compare the proportion of anxiety and depression among spouses of males with alcohol use disorder with spouses of males without alcohol use disorder.Subject or material and methods: We conducted a comparative study on patients attending the general practice OPD of an urban tertiary care hospital. Two groups were taken – wives of men with alcohol use disorder (diagnosed by DSM-5) and wives of those without alcohol use disorder. A semi-structured questionnaire, PHQ-9 and GAD-7 were administered.Results: : 58 women (38%) and 89 women (59%) married to men with alcohol use disorder reported depression and anxiety respectively, as opposed to 26 women (17%) and 58 women (38%) married to men without alcohol use disorder. The difference was significant with odds ratio of 3.01 and 2.31 respectively.Discussion: The rates found were comparable to previous similar studies. However, this study better elucidates the causality of psychiatric morbidity among spouses of men with alcohol dependence as it is a comparative study.Conclusions: Wives of men with alcohol use disorder show significantly higher rates of both depression and anxiety when compared with wives of men without alcohol use disorder. This increased psychiatric morbidity not only affects the individual, but the entire family unit, reduces effective participation in treatment and affects the overall quality of life of the family. Thus it is important to be vigilant about it and intervene in a timely manner.
- 18 December 2017
- Published by Komitet Redakcyjno - Wydawniczy Polskiego Towarzystwa Psychiatrycznego in Archives of Psychiatry and Psychotherapy
- Vol. 19 (4) , 51-56
Open AccessAnxiety and depression in spouses of males diagnosed with alcohol dependence: a comparative study
Aim of the study: In this study, we aim to compare the proportion of anxiety and depression among spouses of males with alcohol use disorder with spouses of males without alcohol use disorder.Subject or material and methods: We conducted a comparative study on patients attending the general practice OPD of an urban tertiary care hospital. Two groups were taken – wives of men with alcohol use disorder (diagnosed by DSM-5) and wives of those without alcohol use disorder. A semi-structured questionnaire, PHQ-9 and GAD-7 were administered.Results: : 58 women (38%) and 89 women (59%) married to men with alcohol use disorder reported depression and anxiety respectively, as opposed to 26 women (17%) and 58 women (38%) married to men without alcohol use disorder. The difference was significant with odds ratio of 3.01 and 2.31 respectively.Discussion: The rates found were comparable to previous similar studies. However, this study better elucidates the causality of psychiatric morbidity among spouses of men with alcohol dependence as it is a comparative study.Conclusions: Wives of men with alcohol use disorder show significantly higher rates of both depression and anxiety when compared with wives of men without alcohol use disorder. This increased psychiatric morbidity not only affects the individual, but the entire family unit, reduces effective participation in treatment and affects the overall quality of life of the family. Thus it is important to be vigilant about it and intervene in a timely manner.
- 1 April 2013
- Published by Elsevier in The American Journal of Medicine
- Vol. 126 (4) , 319-326.e2
Electrocardiographic Abnormalities and Reclassification of Cardiovascular Risk: Insights from NHANES-III
- 1 April 2013
- Published by Elsevier in The American Journal of Medicine
- Vol. 126 (4) , 319-326.e2
Electrocardiographic Abnormalities and Reclassification of Cardiovascular Risk: Insights from NHANES-III
- 1 August 2012
- Published by Elsevier in The American Journal of Cardiology
- Vol. 110 (4) , 521-525
Isolated Nonspecific ST-Segment and T-Wave Abnormalities in a Cross-Sectional United States Population and Mortality (from NHANES III)
- 1 August 2012
- Published by Elsevier in The American Journal of Cardiology
- Vol. 110 (4) , 521-525
Isolated Nonspecific ST-Segment and T-Wave Abnormalities in a Cross-Sectional United States Population and Mortality (from NHANES III)
- Open Access
- 17 July 2012
- Published by Elsevier in Medical Hypotheses
- Vol. 79 (4) , 448-451
Combined use of direct renin inhibitor and carvedilol in heart failure with preserved systolic function
- 17 July 2012
- Published by Elsevier in Medical Hypotheses
- Vol. 79 (4) , 448-451
Open AccessCombined use of direct renin inhibitor and carvedilol in heart failure with preserved systolic function
- 1 July 2012
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 19 (4) , 261-268
Statin Therapy Significantly Reduces Risk of Ventricular Tachyarrhythmias in Patients With an Implantable Cardioverter Defibrillator
A few observational studies have shown the protective effect of statins on preventing ventricular tachycardia/ventricular fibrillation (VT/VF). However, the disparate study results prompt further exploration of this concept. We performed a meta-analysis to assess whether statin therapy is associated with a decrease in the incidence or recurrence of VT/VF in patients with an implantable cardioverter-defibrillator (ICD).The MEDLINE(®) and Cochrane databases were searched from 1980 to July 2009 for studies examining the effect of statins on VT/VF in recipients of ICDs. We retrieved all prospective cohort studies that examined this association. The endpoint was defined as appropriate ICD therapy for VT/VF. The quality of individual studies was assessed using the Newcastle Ottawa Scale.Seven prospective cohort studies met our inclusion criteria with a total of 2278 patients with a mean follow-up of 19.7 months. Pooled analysis of the eligible studies revealed that statin therapy was associated with a 45% reduction in the risk of developing VT/VF in recepients of ICDs [pooled odds ratio (pOR): 0.55; 95% confidence interval: 0.34-0.90; heterogeneity I(2) = 81%, P = 0.02]. In a subgroup analysis, the magnitude of the risk reduction in patients with ischemic cardiomyopathy was 54% (pOR: 0.46, P = 0.05). Sensitivity analysis including studies with higher methodological qualities alone showed a significant protective effect (pOR: 0.48, P = 0.01). There was no evidence of publication bias in the analysis.Our meta-analysis suggests an association between the use of statin and a reduction in the VT/VF occurrence in recipients of ICDs, mainly in patients with ischemic cardiomyopathy.
- 1 July 2012
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 19 (4) , 261-268
Statin Therapy Significantly Reduces Risk of Ventricular Tachyarrhythmias in Patients With an Implantable Cardioverter Defibrillator
A few observational studies have shown the protective effect of statins on preventing ventricular tachycardia/ventricular fibrillation (VT/VF). However, the disparate study results prompt further exploration of this concept. We performed a meta-analysis to assess whether statin therapy is associated with a decrease in the incidence or recurrence of VT/VF in patients with an implantable cardioverter-defibrillator (ICD).The MEDLINE(®) and Cochrane databases were searched from 1980 to July 2009 for studies examining the effect of statins on VT/VF in recipients of ICDs. We retrieved all prospective cohort studies that examined this association. The endpoint was defined as appropriate ICD therapy for VT/VF. The quality of individual studies was assessed using the Newcastle Ottawa Scale.Seven prospective cohort studies met our inclusion criteria with a total of 2278 patients with a mean follow-up of 19.7 months. Pooled analysis of the eligible studies revealed that statin therapy was associated with a 45% reduction in the risk of developing VT/VF in recepients of ICDs [pooled odds ratio (pOR): 0.55; 95% confidence interval: 0.34-0.90; heterogeneity I(2) = 81%, P = 0.02]. In a subgroup analysis, the magnitude of the risk reduction in patients with ischemic cardiomyopathy was 54% (pOR: 0.46, P = 0.05). Sensitivity analysis including studies with higher methodological qualities alone showed a significant protective effect (pOR: 0.48, P = 0.01). There was no evidence of publication bias in the analysis.Our meta-analysis suggests an association between the use of statin and a reduction in the VT/VF occurrence in recipients of ICDs, mainly in patients with ischemic cardiomyopathy.
- 19 June 2012
- Published by SAGE Publications in Angiology
- Vol. 63 (6) , 480-481
The HARD2C Score for Predicting Asymptomatic Peripheral Arterial Disease
- 19 June 2012
- Published by SAGE Publications in Angiology
- Vol. 63 (6) , 480-481
The HARD2C Score for Predicting Asymptomatic Peripheral Arterial Disease
- 1 April 2012
- Published by Elsevier in The American Journal of Cardiology
- Vol. 109 (8) , 1238
Role of Lipid Lowering Therapy and Renin Angiotensin Blockade in Outcomes of Patients With Atrial Fibrillation
- 1 April 2012
- Published by Elsevier in The American Journal of Cardiology
- Vol. 109 (8) , 1238
Role of Lipid Lowering Therapy and Renin Angiotensin Blockade in Outcomes of Patients With Atrial Fibrillation
- Open Access
- 13 February 2012
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 172 (3) , 275-277
Healthy Eating Index and Mortality in a Nationally Representative Elderly Cohort
The Healthy Eating Index (HEI) is a tool developed by the US Department of Agriculture's Center for Nutrition Policy and Promotion in 1995 for evaluating diet quality and monitoring changes in dietary practices in the US population.1 Prior studies have demonstrated an association between a “good” HEI score and lower incidence of cardiovascular disease2,3 and accompanying risk factors.4,5 However, literature on the prognostic utility of HEI in an exclusively geriatric population is sparse. We sought to investigate whether there is a correlation between favorable HEI scores and all-cause as well as cardiovascular mortality in the elderly US population.
- 13 February 2012
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 172 (3) , 275-277
Open AccessHealthy Eating Index and Mortality in a Nationally Representative Elderly Cohort
The Healthy Eating Index (HEI) is a tool developed by the US Department of Agriculture's Center for Nutrition Policy and Promotion in 1995 for evaluating diet quality and monitoring changes in dietary practices in the US population.1 Prior studies have demonstrated an association between a “good” HEI score and lower incidence of cardiovascular disease2,3 and accompanying risk factors.4,5 However, literature on the prognostic utility of HEI in an exclusively geriatric population is sparse. We sought to investigate whether there is a correlation between favorable HEI scores and all-cause as well as cardiovascular mortality in the elderly US population.
- 1 February 2012
- Published by Elsevier in The American Journal of Cardiology
- Vol. 109 (4) , 600
Long-Term Mortality and Role of Troponin Elevation in Hypertensive Emergencies
- 1 February 2012
- Published by Elsevier in The American Journal of Cardiology
- Vol. 109 (4) , 600
Long-Term Mortality and Role of Troponin Elevation in Hypertensive Emergencies